September: a month of premieres and emotions with the Emmys in sight on television.

September presents itself as a vibrant month for television lovers, not only due to the arrival of new seasons of highly anticipated series but also because the grand event of the Emmys is approaching, set to take place on September 15th. This year, the spotlight is on "The Bear," which has garnered an impressive number of nominations, and "The Morning Show," which, with its stellar cast, aims to turn its multiple nominations into awards. The competition promises to be fierce, and fans are wondering if this will be the year for series like "Slow Horses." Anticipation intensifies with the return of "Slow Horses," starring the talented Gary Oldman, who will premiere its fourth season shortly after the third is nominated for the Emmys. This series has captivated critics and audiences alike, becoming one of the gems of the current catalog. The presence of an actor of Oldman's caliber always raises expectations and promises an intriguing narrative that will not disappoint. However, not all actors manage to be part of the Emmy conversation. Colin Farrell, who could not present himself for these awards with "The Penguin," has seen his performance in "Sugar" left out of the running. This serves as a clear reminder that, often, awards do not reflect true talent, and recognition frequently does not come when expected. On another note, the series "Frasier" returns with a second season also set to premiere in September. Kelsey Grammer, who earned four Emmys for his role in the original series, has been unable to replicate that success with this late sequel. The anticipation for how this new installment will unfold is palpable, and fans hope it captures the essence that made its predecessor great. In the European realm, productions also have their place in the conversation. Series like "Rapa" and "My Brilliant Friend" join the list of September releases, with the former presenting its third season and the latter its fourth and final one. Both have proven to be strong competitors, capable of challenging major North American productions on more than one occasion. Javier Bardem, the renowned Spanish actor, once again serves as a bridge between Hollywood productions and European narratives. His involvement in the new installment of "Monsters," a Ryan Murphy series for Netflix that explores the lives of infamous criminals, promises to be a captivating spectacle. This connection between two different worlds of television offers a rich diversity of stories that are sure to resonate with international audiences. On Netflix, Nicole Kidman will also be seen in a new role as a "disturbing millionaire," a character that seems to be a trademark in her career. This trend of portraying complex characters that challenge societal norms is something Kidman has skillfully managed throughout her career. Carole Bouquet, on Apple TV+, joins this phenomenon, demonstrating that the allure of these characters continues to capture the public's attention. For those seeking more daring and provocative television experiences, "Dinosaur" and "Agatha" emerge as attractive options on the horizon. These series have generated expectations due to their themes and styles, and many are wondering if they will make an impact in the upcoming awards season. The quest for bold and groundbreaking narratives has become a hallmark of contemporary television. With so many options and the arrival of such significant awards, September opens up as a battleground of creativity and talent. Expectations are high, and the uncertainty of who will take home the awards fuels the conversation surrounding these productions. Fans will have a month full of emotions, surprises, and, above all, the opportunity to rediscover the power of storytelling through the screen. As the Emmy gala approaches, the lingering question is: which of these series will achieve recognition in the pantheon of television? Only time will tell, but one thing is certain: September will be an unforgettable month for small-screen enthusiasts.